HomeInsightsStock Comparison

Alembic Pharmaceuticals Ltd vs Gujarat Terce Laboratories Ltd Stock Comparison

Alembic Pharmaceuticals Ltd vs Gujarat Terce Laboratories Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Alembic Pharmaceuticals Ltd is ₹ 1024 as of 16 Jul 15:30.
  • The P/E Ratio of Alembic Pharmaceuticals Ltd changed from 12.1 on March 2020 to 31.3 on March 2025 . This represents a CAGR of 17.16% over 6 yearsThe P/E Ratio of Gujarat Terce Laboratories Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Alembic Pharmaceuticals Ltd changed from ₹ 10059 crore on March 2020 to ₹ 18265 crore on March 2025 . This represents a CAGR of 10.45% over 6 yearsThe Market Cap of Gujarat Terce Laboratories Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 1783 crore as compare to the Dec '24 revenue of ₹ 1702 crore. This represent the growth of 4.77% The revenue of Gujarat Terce Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Alembic Pharmaceuticals Ltd for the Mar '25 is ₹ 285.46 crore as compare to the Dec '24 ebitda of ₹ 270.08 crore. This represent the growth of 5.69% The ebitda of Gujarat Terce Laboratories Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Alembic Pharmaceuticals Ltd changed from ₹ 120.6 crore to ₹ 156.63 crore over 8 quarters. This represents a CAGR of 13.96% The net profit of Gujarat Terce Laboratories Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Alembic Pharmaceuticals Ltd changed from 19.45 % on March 2020 to 42.97 % on March 2025 . This represents a CAGR of 14.12% over 6 yearsThe Dividend Payout of Gujarat Terce Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Alembic Pharmaceuticals Ltd

  • Alembic Pharmaceuticals Limited manufactures and markets generic pharmaceutical products all over the world.
  • The company's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the US FDA. The company is one of the leaders in branded generics in India. Alembic Pharmaceuticals Limited was incorporated on June 16, 2010 as a wholly owned subsidiary of Alembic Limited.
  • The company is engaged in pharmaceuticals business.
  • As per the Scheme of Arrangement, the 'Pharmaceutical Undertaking' of Alembic Limited got demerged and transferred to the Company with effect from April 1, 2010. In April 2011, the company ceased to be a subsidiary of Alembic Ltd consequent to the allotment of 13,35,15,914 equity shares of Rs 2 each to the shareholders of Alembic Ltd as per the scheme of arrangement.

About Gujarat Terce Laboratories Ltd

  • Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market.
  • Over its more than three-decade business journey, the Company developed an extensive product basket comprising 50 brands covering multiple therapeutic areas which are marketed by its 180+ strong MR team across 13 Indian states.
  • Headquartered in Ahmedabad, the Company has its fully automated facility at Chhatral, in Gandhinagar, Gujarat By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing.
  • In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange.
  • In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat.

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma appoints G. Krishnan as new CFO

Krishnan is a seasoned finance professional with over 22 years of experience across the ph...

Read more

07 Jul 2025 14:58

News

Alembic Pharmaceuticals announces acquisition of Utility Therapeutics

Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals has acqui...

Read more

03 Jul 2025 09:15

News

Alembic Pharma inks deal to acquire Utility Therapeutics for $12 million

Utility Therapeutics is involved in the development and approval of two brand pharmaceutic...

Read more

03 Jul 2025 10:40

News

Alembic Pharma jumps after receiving USFDA nod for Doxorubicin Hydrochloride Injection

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

30 Jun 2025 10:12

News

Alembic Pharmaceuticals Ltd leads gainers in 'A' group

Jindal Worldwide Ltd, RattanIndia Power Ltd, AAVAS Financiers Ltd and Force Motors Ltd are...

Read more

30 Jun 2025 12:00

News

Volumes soar at Alembic Pharmaceuticals Ltd counter

Jyoti CNC Automation Ltd, Raymond Ltd, TBO Tek Ltd, Raymond Lifestyle Ltd are among the ot...

Read more

30 Jun 2025 14:30

Gujarat Terce Laboratories Ltd News Hub

News

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

10 Jul 2025 10:17

News

Gujarat Terce Laboratories to discuss results

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

20 May 2025 16:53

News

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

27 Jan 2025 14:03

News

Gujarat Terce Laboratories to declare Quarterly Result

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

18 Oct 2024 17:17

News

Gujarat Terce Laboratories to convene AGM

Gujarat Terce Laboratories announced that the Annual General Meeting (AGM) of the company ...

Read more

20 Aug 2024 16:03

News

Gujarat Terce Laboratories to conduct board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

03 Aug 2024 17:01

SWOT Analysis Of Alembic Pharmaceuticals Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Gujarat Terce Laboratories Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Alembic Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Gujarat Terce Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Alembic Pharmaceuticals Ltd and Gujarat Terce Laboratories Ltd

Which company has a larger market capitalization, Alembic Pharmaceuticals Ltd or Gujarat Terce Laboratories Ltd?

Market cap of Alembic Pharmaceuticals Ltd is 20,130 Cr while Market cap of Gujarat Terce Laboratories Ltd is 36 Cr

What are the key factors driving the stock performance of Alembic Pharmaceuticals Ltd and Gujarat Terce Laboratories Ltd?

The stock performance of Alembic Pharmaceuticals Ltd and Gujarat Terce Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alembic Pharmaceuticals Ltd and Gujarat Terce Laboratories Ltd?

As of July 16, 2025, the Alembic Pharmaceuticals Ltd stock price is INR ₹1024.1. On the other hand, Gujarat Terce Laboratories Ltd stock price is INR ₹49.29.

How do dividend payouts of Alembic Pharmaceuticals Ltd and Gujarat Terce Laboratories Ltd compare?

To compare the dividend payouts of Alembic Pharmaceuticals Ltd and Gujarat Terce Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions